Search

Financial results - NEUROPROGRESS MED S.R.L.

0.00
Financial Summary - Neuroprogress Med S.r.l.
Unique identification code: 45553329
Registration number: J2022000049193
Nace: 8622
Sales - Ron
95.008
Net Profit - Ron
40.231
Employees
2
Open Account
Company Neuroprogress Med S.r.l. with Fiscal Code 45553329 recorded a turnover of 2024 of 95.008, with a net profit of 40.231 and having an average number of employees of 2. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Neuroprogress Med S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 27.204 71.031 95.008
Total Income - EUR - - - - - - - 27.206 71.044 95.009
Total Expenses - EUR - - - - - - - 14.608 36.595 52.356
Gross Profit/Loss - EUR - - - - - - - 12.598 34.449 42.654
Net Profit/Loss - EUR - - - - - - - 12.532 34.068 40.231
Employees - - - - - - - 1 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 34.5%, from 71.031 euro in the year 2023, to 95.008 euro in 2024. The Net Profit increased by 6.354 euro, from 34.068 euro in 2023, to 40.231 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Neuroprogress Med S.r.l.

Rating financiar

Financial Rating -
NEUROPROGRESS MED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Neuroprogress Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neuroprogress Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Neuroprogress Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neuroprogress Med S.r.l. - CUI 45553329

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 6 72.139 63.297
Current Assets - - - - - - - 19.803 15.195 33.417
Inventories - - - - - - - 0 0 383
Receivables - - - - - - - 3.567 8.679 960
Cash - - - - - - - 16.236 6.516 32.074
Shareholders Funds - - - - - - - 12.573 46.603 82.422
Social Capital - - - - - - - 0 0 0
Debts - - - - - - - 7.236 40.732 14.292
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 33.417 euro in 2024 which includes Inventories of 383 euro, Receivables of 960 euro and cash availability of 32.074 euro.
The company's Equity was valued at 82.422 euro, while total Liabilities amounted to 14.292 euro. Equity increased by 36.080 euro, from 46.603 euro in 2023, to 82.422 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Neuroprogress Med S.r.l.

Comments - Neuroprogress Med S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.